Abbott’s AVEIR™ DR i2i™ IDE study is the industry’s first prospective study on the safety and performance of the world’s first dual-chamber leadless pacemaker The study successfully met all three of its primary safety and performance endpoints Abbott’s investigational AVEIR DR leadless…

NEW YORK, May 20, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Telephone & Data Systems, Inc. (“TDS” or the “Company”) (NYSE: TDS, TDSPrU and TDSPrV) and reminds investors of the July 3, 2023 deadline to seek…

NEW YORK, May 20, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Vertex Energy, Inc. (“Vertex” or the “Company”) (NASDAQ: VTNR) and reminds investors of the June 12, 2023 deadline to seek the role of lead…

NEW YORK, May 20, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Block, Inc. f/k/a Square, Inc. (“Block” or the “Company”) (NYSE: SQ). If you suffered losses exceeding $50,000 investing in Block stock or options…

NEW YORK, May 20, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Chinook Therapeutics, Inc. (“Chinook” or the “Company”) (NASDAQ: KDNY). If you suffered losses exceeding $50,000 investing in Chinook stock or…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.